Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND hCG AND Diagnosis
13 results:

  • 1. [Clinicopathological analysis of lung metastatic tumor].
    Lou N; Niu YR; Yang F; Lu ZH
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1039-1044. PubMed ID: 34496496
    [No Abstract]    [Full Text] [Related]  

  • 2. A rare case of primary rectal choriocarcinoma and review of the literature.
    Telli TA; Demircan NC; Alan O; Tuylu TB; Arikan R; Ercelep O; Atıcı AE; Ergelen R; Seven IE; Babacan NA; Kaya S; Dane F; Fulden Yumuk P
    J Oncol Pharm Pract; 2020 Jun; 26(4):989-994. PubMed ID: 31547751
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discrepant serum and urine β-hcg results due to production of β-hcg by a cribriform-morular variant of thyroid papillary carcinoma.
    Alikhan M; Koshy A; Hyjek E; Stenson K; Cohen RN; Yeo KT
    Clin Chim Acta; 2015 Jan; 438():181-5. PubMed ID: 25181612
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement.
    Chen C; Chen LQ; Yang GL; Li Y
    J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CEA, CA 242, CA 19-9, CA 72-4 and hcgbeta in the diagnosis of recurrent colorectal cancer.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
    Canil CM; Tannock IF
    Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Tumor markers--personal experience. A case report of primary lung cancer with interesting production of tumor markers].
    Ariyoshi Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1721-5. PubMed ID: 1872630
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Human chorionic gonadotropin-like substance (hcgLS) in male patients with gastrointestinal cancer].
    Ohyama Y
    Nihon Geka Gakkai Zasshi; 1986 Jan; 87(1):20-8. PubMed ID: 2421150
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adenocarcinoma of the colon with syncytiotrophoblastic differentiation: differential diagnosis and implications.
    Metz KA; Richter HJ; Leder LD
    Pathol Res Pract; 1985 Jan; 179(3):419-24. PubMed ID: 4039056
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Human chorionic gonadotropin immunoreactivity in serum of patients with malignant neoplasms.
    Ayala AR; Saad A; Vázquez X; Ramírez-Wiella G; Perches RD
    Am J Reprod Immunol (1980); 1983; 3(3):149-51. PubMed ID: 6869651
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.